Grow the business of today and create the solutions for tomorrow.
“Every day Chr. Hansen’s ingredients are consumed by more than 500 million people worldwide. Yet significant potential remains in the global population of 7 billion people. We wish to meet the continuously growing demand for tasty, healthy, natural, safe and affordable food and nutrition,” says CEO Cees de Jong.
“The new strategy builds on our core competences and is about evolution rather than revolution. We see attractive growth potential within our core businesses and have identified new opportunities for leveraging Chr. Hansen’s strong technology platform within the field of microbial solutions.”
Shaping the future
New focus areas include a stronger presence in emerging markets ? Asia in particular, a new business area “Plant Health” with natural alternatives to chemical crop protection, and increased focus on research within bacteria.
“Good bacteria are becoming an increasingly relevant way to address unmet consumer and customer needs in an all-natural way, and we have the technology to develop new and relevant solutions. We are excited about shaping our future. Simply put, we wish to be Nature’s No. 1,” concludes Cees de Jong.
The strategy consists of six overall themes:
1. Fully leveraging the potential of the Cultures & Enzymes Division
2. Developing the microbial solutions platform in the Health & Nutrition Division
3. Creating further value in the Natural Colors Division
4. Reinforcing Chr. Hansen’s position in emerging markets ? especially Asia
5. Driving a step change in innovation
6. Generating the fuel for growth
For further details about each strategic theme and Chr. Hansen’s financial ambitions, please read today’s company announcement “Strategy update: Nature’s No. 1”.
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.